Skip to main content

Table 3 clinical data of patients with LPL deficiency

From: Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis

 

HPND

N = 20

HTG

N = 30

HPD

N = 5

P

Age

47 ± 8

47 ± 7

23 ± 6

<0.001*

Age first onset AP

40 ± 11

-

6 ± 6

<0.001**

Episode AP number

1.75 ± 0.85

-

2.5 ± 0.6

NS

Sex (Male)

19 (95%)

27 (90%)

3 (60)%

NS

Smokers

15 (75%)

19 (63%)

-

0.006*

HLP AF

10 (50%)

12 (40%)

4 (80%)

NS

Fibrates

13 (68%)

18 (58%)

-

NS

BMI

27.4 ± 3.6

29.7 ± 4.8

21.3 ± 1.6

0.01

  1. HPD: patients with LPL deficiency.
  2. *Differences between HPD and the others groups.
  3. **: Differences between HPND and HPD.